TOP NEWS

Viking Therapeutics Raises $12.5M In PIPE

San Diego-based biopharmaceutiacls developer Viking Therapeutics says it has raised $12.5M in a common stock purchase agreement, from Aspire Capital Fund. The company, which is publicly traded on the NASDAQ as VKTX, said the initial purchase came at $1.50 per share, with the remaining $12M to be purchase over the next 30 months at prices based on the market price. Viking Therapeutics is developing treatments for metabolic and endocrine disorders.


LATEST HEADLINES

More Headlines

BROWSE ISSUES